Real-time enrollment status for this pancreatic ductal adenocarcinoma clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 11:39 AM UTC
| NCT Number | NCT06586515 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Ductal Adenocarcinoma |
| Phase | PHASE1 |
| Target Enrollment | 630 participants |
| Active Locations | 25 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | August 24, 2026 (3 days ago) |
As of August 27, 2026: Clinical trial NCT06586515 is currently recruiting participants. This phase1 study for pancreatic ductal adenocarcinoma is actively seeking new participants at 25 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06586515 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 25 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06586515 was last updated 3 days ago (August 24, 2026). HelloStudys verifies this status automatically.